Detalles de la búsqueda
1.
Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).
Ann Surg Oncol
; 30(2): 1099-1109, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305992
2.
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727).
Cancer
; 120(19): 2980-5, 2014 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25041791
3.
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336).
Invest New Drugs
; 27(5): 469-75, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18941712
4.
Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro.
Virol J
; 3: 8, 2006 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-16507098
5.
Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making.
Onco Targets Ther
; 8: 959-67, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25960669
6.
Poorly differentiated colon carcinoma with neuroendocrine features presenting with hypercalcemia and cutaneous metastases: case report and review of the literature.
Am J Clin Oncol
; 25(2): 160-3, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11943894
7.
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study.
Invest New Drugs
; 24(4): 335-41, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16683076
8.
A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group study.
Invest New Drugs
; 24(6): 515-20, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16699973
9.
A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study.
Invest New Drugs
; 23(5): 485-7, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16133800
10.
A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
Cancer
; 100(8): 1699-704, 2004 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15073859
11.
Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study.
J Immunother
; 25(4): 352-8, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12142558
12.
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.
Invest New Drugs
; 22(4): 467-73, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15292717
13.
A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group study.
Invest New Drugs
; 20(1): 105-11, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12003185
14.
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.
Invest New Drugs
; 22(3): 335-41, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15122082
Resultados
1 -
14
de 14
1
Próxima >
>>